Daily bulletin: Narendra Modi to co-chair ASEAN-India summit in Thailand; Delhi HC Bar Association asked to join strike against Tis Hazari scuffle; day's top stories

-

Modi to attend ASEAN-India, RCEP summits in Thailand

Prime Minister Narendra Modi will participate in a business event and attend the ASEAN-India summit with the Thailand prime minister Prayut Chan-o-cha. The India-ASEAN Summit will begin at 11.15 am and continue till 12.15 pm (IST). After the summit, Modi will hold a meeting with his Thailand counterpart. Modi is also scheduled to hold a meeting with Indonesia President Joko Widodo and Myanmar state counsellor Aung San Suu Kyi.

Prime Minister Narendra Modi addresses the crowd during the 'Sawasdee PM ModiĀ’ event in Bangkok. PTI

Prime Minister Narendra Modi addresses the crowd during the 'Sawasdee PM Modi’ event in Bangkok. PTI

Prime Minister Narendra Modi on Saturday reached Bangkok to attend the Association of Southeast Asian Nations (ASEAN)-India, East Asia and Regional Comprehensive Economic Partnership (RCEP) summits. PM Modi will attend the 16th ASEAN-India Summit, the 14th East Asia Summit and the third summit meeting of RCEP.

BJP announces candidates for Assembly bypolls in Uttarakhand, West Bengal

The BJP announced its candidates for the assembly by-polls in Uttarakhand and West Bengal. The party's central election committee finalised the names for the bypoll on one Assembly seat in Uttarakhand and three in West Bengal, the BJP said in a statement. Chandra Pant will be the party's candidate for Pithoragarh seat in Uttarakhand.

Kamal Chandra Sarkar, Joyprakash Majumder and Premchand Jha are the BJP nominees for Kaliaganj, Karimpur and Kharagpur Sadar Assembly seats respectively in West Bengal.

Polling in these four assembly seats is scheduled for 25 November.

Nawaf Sharif remains critical; Abbasi rushed to hospital

Former Pakistan prime minister Nawaz Sharif continues to remain critical and his platelet count has dropped again even as doctors are trying to reduce the steroid dose being administered to the ailing leader. "Former PM #NawazSharif remains critical. The treating doctors tried to reduce the Steroids dose being given to him but unfortunately resulted in a drop in Platelet count again. The cause needs to be diagnosed & established without delay," Sharif's personal physician Adnan Khan tweeted on Saturday.

"Severe existent co-morbidities has added to the seriousness of the nature of the critical illness, where a very delicate balance has to be maintained between coagulation & anti-coagulation to sustain fragile unstable health status," he said in a follow-up tweet.

Sharif, who was admitted to Lahore's Services Hospital on October 22, is being treated under the supervision of the special medical board of the hospital.

Meanwhile, former Pakistan prime minister Shahid Khaqan Abbasi was shifted to the Pakistan Institute of Medical Sciences (PIMS) hospital for a check-up on Saturday after his health condition deteriorated. The Pakistan Muslim League-Nawaz (PML-N) leader was brought to the hospital by jail officials from Adiala Jail in Rawalpindi where he is incarcerated in connection with the liquefied natural gas (LNG) scam, according to Pakistani media reports. Abbasi underwent a check-up for hernia, heart and lungs, PIMS spokesperson Dr Wasim was quoted by Geo News as saying.

Delhi HC Bar Association asked to join strike against Tis Hazari scuffle

Taking cognisance into the strike called by the Bar Council of India over the scuffle that broke out between lawyers and Delhi Police personnel at Tis Hazari Court, members of the Delhi High Court Bar Association (DHCBA) have been requested to abstain from work on Monday and support the protest.

To avoid inconvenience to the courts and litigants, the DHCBA will depute proxy counsel in every court and a list of proxy counsel will be duly circulated. The DHCBA urged Chief Justice of Delhi High Court, Justice DN Patel to order an immediate judicial inquiry into the incident and to recommend action against the "delinquent" police officials, following which the concerned DCP and ACP will be placed under suspension.

The lawyers' association have demanded that an FIR should be registered against the police officers for their "criminal acts".

Aramco IPO to open today; Saudi Crown Prince gives go-ahead

Saudi Arabia's Crown Prince Mohammed bin Salman on Friday agreed that the initial public offering of state oil giant Aramco will be announced on Sunday, five sources familiar with the matter told Reuters. The world's top oil company will announce its intention to float (ITF) on 3 November, the sources said. "The crown prince finally gave the green light," one source said.

Aramco declined to comment.

The much-awaited IPO of Aramco will come “soon”, the Gulf kingdom’s energy minister had announced on Wednesday, according to PTI. “It will be a Saudi decision, first and foremost. Specifically, Prince Mohammed’s decision,” he said, referring to powerful Crown Prince Mohammed bin Salman.

The IPO forms the cornerstone of a reform programme conceived by the kingdom's de facto ruler Crown Prince Mohammed bin Salman to wean the Saudi economy off its reliance on oil. But there have been various delays since it was first announced in 2016. Aramco, which pumps about 10 percent of the world’s crude oil, emerged as the world’s most profitable company in 2018.

Upbeat India face Bangladesh in 1st T20I in New Delhi

India enter as favourites in the three-match T20I series against Bangladesh, the first match of which takes place at New Delhi's newly-christened Arun Jaitley Stadium. Bangladesh are without star all-rounder Shakib Al Hasan, who was handed a two-year ban by the ICC for failing to report a corrupt approach, while India are without the services of Virat Kohli, who has been rested by the selectors with Rohit Sharma leading the 'Men in Blue' in his stead.



from Firstpost India Latest News https://ift.tt/2NbV3Ej
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more